Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.
Saved in:
| Title: | Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial. |
|---|---|
| Authors: | Khong J; Department of Psychology, University of California, Los Angeles, CA, USA., Lee M; Department of Biochemistry, University of California, Los Angeles, CA, USA., Warren C; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Kim UB; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Duarte S; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Andreoni KA; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, USA., Shrestha S; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Johnson MW; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Battula NR; Department of Surgery, College of Medicine, University of Oklahoma, Oklahoma City, OK, USA., McKimmy DM; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Beduschi T; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA., Lee JH; Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL, USA.; Division of Quantitative Sciences, University of Florida Health Cancer Center, University of Florida, Gainesville, FL, USA., Li DM; Division of Quantitative Sciences, University of Florida Health Cancer Center, University of Florida, Gainesville, FL, USA., Ho CM; Department of Mechanical and Aerospace Engineering, Henry Samueli School of Engineering, University of California, Los Angeles, CA, USA., Zarrinpar A; Department of Surgery, College of Medicine, University of Florida, Gainesville, FL, USA. Ali.Zarrinpar@surgery.ufl.edu. |
| Source: | Nature communications [Nat Commun] 2025 May 16; Vol. 16 (1), pp. 4558. Date of Electronic Publication: 2025 May 16. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-59739-6 |
